Nav: Home

Andrew Holmes given the ACNP Daniel H. Efron Research Award

December 05, 2016

The American College of Neuropsychopharmacology (ACNP) has named Andrew Holmes, Ph.D. as one of two winners of the 2016 Daniel H. Efron Research Award. Dr. Holmes directs the Laboratory of Behavioral and Genomic Neuroscience at the National Institute on Alcohol Abuse and Alcoholism (NIAAA). This award, presented at the 55th Annual Meeting of the ACNP in Hollywood, Florida, is in recognition of outstanding basic research contributions to neuropsychopharmacology. The contributions may be preclinical or work that emphasizes the interface between basic and clinical research. The selection of the awardee is based on the quality of the contribution and its impact in advancing neuropsychopharmacology.

Dr. Holmes' work is focused on understanding of the causes of alcoholism and comorbid neuropsychiatric conditions such as mood and anxiety disorders. Over his career, he has performed innovative studies using rodent models of chronic alcohol exposure and chronic stress to examine how these factors influence behavior, brain physiology and brain neurocircuitry. His work emphasizes individual differences, including genetic factors as well as the role of the environment, sex and age. He has made major contributions to our understanding of the prefrontal cortex to limbic and dorsal striatal circuits, which hare known to be critical for the regulation of emotion, cognition and executive control over drug-seeking.

Dr. Holmes has published a total of 170 research articles and reviews, many of which are in journals considered to be top tier in his field of research, together these publications have been cited more than 13,000 times. He has been the recipient of a number of other awards from prestigious professional groups, including the A. E. Bennett Award of the Society of Biological Psychiatry. He serves in editorial roles for eight professional journals, and has served as a mentor for a number of young investigators who have gone on to successful research careers themselves.
-end-
ACNP, founded in 1961, is a professional organization of more than 1000 leading scientists, including four Nobel Laureates. The mission of ACNP is to further research and education in neuropsychopharmacology and related fields in the following ways: promoting the interaction of a broad range of scientific disciplines of brain and behavior in order to advance the understanding of prevention and treatment of disease of the nervous system including psychiatric, neurological, behavioral and addictive disorders; encouraging scientists to enter research careers in fields related to these disorders and their treatment; and ensuring the dissemination of relevant scientific advances.

American College of Neuropsychopharmacology

Related Alcoholism Articles:

Alcoholism without borders
In some former Soviet bloc countries, men often die early due to alcohol abuse.
Study reveals genes associated with heavy drinking and alcoholism
A large genomic study of nearly 275,000 people led by Penn Medicine researchers revealed new insights into genetic drivers of heavy drinking and alcohol use disorder (AUD), the uncontrollable pattern of alcohol use commonly referred to as alcoholism.
Social anxiety disorder may increase risk of alcoholism
New research published in Depression and Anxiety indicates that, unlike other anxiety disorders, social anxiety disorder may have a direct effect on alcoholism.
Study identifies new target to prevent, treat alcoholism
New research conducted at OHSU in Portland, Oregon, identifies a gene that could provide a new target for developing medication to prevent and treat alcoholism.
It's all in your head: Brain protein targeted for alcoholism cure
University of Houston chemist Joydip Das is reporting a cure for alcoholism could be found in a protein inside the brain that plays a big role in developing tolerance to drinking.
Building and breaking connections: How neuronal networks influence alcoholism
Although it has been known that alterations in the connections between neurons in the brain likely play a role in alcohol dependence and other addictions, the cause-and-effect between these brain alterations and behavior has been less clear.
Where to look for new treatments for alcoholism? The matrix
A new study in Biological Psychiatry may pave the way for treating alcohol addiction by reducing motivation to drink, rather than by altering the effects of alcohol itself.
Could OTC medicines be the answer to alcoholism?
The study is determining if two over-the-counter (OTC) medications can diminish alcohol abuse in diagnosed bipolar patients.
Alcoholism may be caused by dynamical dopamine imbalance
Researchers from the Higher School of Economics, Ecole Normale Supérieure, Paris, Indiana University and the Russian Academy of Sciences Nizhny Novgorod Institute of Applied Physics have identified potential alcoholism mechanisms, associated with altered dopaminergic neuron response to complex dynamics of prefrontal cortex neurones affecting dopamine release.
Drug shows promise for treating alcoholism
A new study by UCLA researchers has found that an anti-inflammatory drug called Ibudilast, used in Japan to treat asthma, may be a promising new treatment for alcoholism.
More Alcoholism News and Alcoholism Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.